Search Results - Stuart Elborn

Refine Results
  1. 1

    The impact of personalised therapies on respiratory medicine by J. Stuart Elborn

    Published in European Respiratory Review (2013-03-01)
    Get full text
    Article


  2. 2

    Basic, translational and clinical aspects of bronchiectasis in adults by James D. Chalmers, Stuart Elborn, Catherine M. Greene

    Published in European Respiratory Review (2023-06-01)
    Get full text
    Article


  3. 3

    Personalising airway clearance in chronic lung disease by Maggie McIlwaine, Judy Bradley, J. Stuart Elborn, Fidelma Moran

    Published in European Respiratory Review (2017-02-01)
    Get full text
    Article


  4. 4

    Changing epidemiology and clinical issues arising in an ageing cystic fibrosis population by Michael D. Parkins, Vicky M. Parkins, Jackie C. Rendall, Stuart Elborn

    Get full text
    Article


  5. 5

    In vitro activity of cefiderocol against Gram-negative pathogens isolated from people with cystic fibrosis and bronchiectasis by Michael M Tunney, J Stuart Elborn, Chloe S McLaughlin, Christopher M Longshaw

    Published in Journal of Global Antimicrobial Resistance (2024-03-01)
    Get full text
    Article


  6. 6

    Discrete choice experiment (DCE) to quantify the influence of trial features on the decision to participate in cystic fibrosis (CF) clinical trials by Frank Kee, Jane C Davies, Rebecca Anne Dobra, Marco Boeri, Stuart Elborn, Susan Madge

    Published in BMJ Open (2021-03-01)
    Get full text
    Article


  7. 7

    A systematic review to identify and collate factors influencing patient journeys through clinical trials by Rebecca Dobra, Gemma Wilson, Jessie Matthews, Marco Boeri, Stuart Elborn, Frank Kee, Jane C Davies, Susan Madge

    Published in JRSM Open (2023-06-01)
    Get full text
    Article


  8. 8

    Lung function and disease severity in cystic fibrosis patients heterozygous for p.Arg117His by Michal Shteinberg, Damian G. Downey, Diane Beattie, John McCaughan, Alastair Reid, Nili Stein, J. Stuart Elborn

    Published in ERJ Open Research (2017-03-01)
    Get full text
    Article


  9. 9

    Community analysis and co-occurrence patterns in airway microbial communities during health and disease by Gisli G. Einarsson, Jiangchao Zhao, John J. LiPuma, Damian G. Downey, Michael M. Tunney, J. Stuart Elborn

    Published in ERJ Open Research (2019-07-01)
    Get full text
    Article


  10. 10

    New strategies of physical activity assessment in cystic fibrosis: a pilot study by Daniela Savi, Luigi Graziano, Barbara Giordani, Stefano Schiavetto, Corrado De Vito, Giuseppe Migliara, Nicholas J. Simmonds, Paolo Palange, J. Stuart Elborn

    Published in BMC Pulmonary Medicine (2020-10-01)
    Get full text
    Article


  11. 11

    The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations. by Anthony A Fodor, Erich R Klem, Deirdre F Gilpin, J Stuart Elborn, Richard C Boucher, Michael M Tunney, Matthew C Wolfgang

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


  12. 12

    Randomised, phase 1/2a trial of ION-827359, an antisense oligonucleotide inhibitor of ENaC by Sivagurunathan Sutharsan, Rainald Fischer, Wolfgang Gleiber, Alex Horsley, Jeff Crosby, Shuling Guo, Shuting Xia, Rosie Yu, Kenneth B. Newman, J. Stuart Elborn

    Published in ERJ Open Research (2024-09-01)
    Get full text
    Article


  13. 13

    Testing two different doses of tiotropium Respimat® in cystic fibrosis: phase 2 randomized trial results. by Judy M Bradley, Paul Koker, Qiqi Deng, Petra Moroni-Zentgraf, Felix Ratjen, David E Geller, J Stuart Elborn, Tiotropium Cystic Fibrosis Study Group

    Published in PLoS ONE (2014-01-01)
    Get full text
    Article


  14. 14

    MRSA eradication of newly acquired lower respiratory tract infection in cystic fibrosis by Emilie Vallières, Jacqueline C. Rendall, John E. Moore, John McCaughan, Anne I. Hoeritzauer, Michael M. Tunney, Joseph Stuart Elborn, Damian G. Downey

    Published in ERJ Open Research (2016-03-01)
    Get full text
    Article


  15. 15

    Taxonomic position, antibiotic resistance and virulence factor production by Stenotrophomonas isolates from patients with cystic fibrosis and other chronic respiratory infections by Ad C. Fluit, Jumamurat R. Bayjanov, María Díez Aguilar, Rafael Cantón, Stuart Elborn, Michael M. Tunney, Jelle Scharringa, Barry J. Benaissa-Trouw, Miquel B. Ekkelenkamp

    Published in BMC Microbiology (2022-05-01)
    Get full text
    Article


  16. 16

    Chest computed tomography outcomes in a randomized clinical trial in cystic fibrosis: Lessons learned from the first ataluren phase 3 study. by Harm A W M Tiddens, Eleni-Rosalina Andrinopoulou, Joe McIntosh, J Stuart Elborn, Eitan Kerem, Nynke Bouma, Jochem Bosch, Mariette Kemner-van de Corput

    Published in PLoS ONE (2020-01-01)
    Get full text
    Article


  17. 17

    Biologically Relevant Murine Models of Chronic <i>Pseudomonas aeruginosa</i> Respiratory Infection by Aoife M. Rodgers, Jaime Lindsay, Avril Monahan, Alice V. Dubois, Aduragbemi A. Faniyi, Barry J. Plant, Marcus A. Mall, Miquel B. Ekkelenkamp, Stuart Elborn, Rebecca J. Ingram

    Published in Pathogens (2023-08-01)
    Get full text
    Article


  18. 18

    Standards of care and educational gaps in adult cystic fibrosis units: a European Respiratory Society survey by Almudena Felipe Montiel, Antonio Álvarez Fernández, Mario Culebras Amigo, Francesco Blasi, Andrea Gramegna, Stuart Elborn, Alexander Horsley, Susan Madge, Daiana Stolz, Nathalie Tabin, Carine Pannetier, Eva Polverino

    Published in ERJ Open Research (2024-05-01)
    Get full text
    Article


  19. 19

    Therapeutic Inhibition of Cathepsin S Reduces Inflammation and Mucus Plugging in Adult βENaC-Tg Mice by Ryan Brown, Donna M. Small, Declan F. Doherty, Leslie Holsinger, Robert Booth, Richard Williams, Rebecca J. Ingram, J. Stuart Elborn, Marcus A. Mall, Clifford C. Taggart, Sinéad Weldon

    Published in Mediators of Inflammation (2021-01-01)
    Get full text
    Article


  20. 20

    Reduced bacterial colony count of anaerobic bacteria is associated with a worsening in lung clearance index and inflammation in cystic fibrosis. by Katherine O'Neill, Judy M Bradley, Elinor Johnston, Stephanie McGrath, Leanne McIlreavey, Stephen Rowan, Alastair Reid, Ian Bradbury, Gisli Einarsson, J Stuart Elborn, Michael M Tunney

    Published in PLoS ONE (2015-01-01)
    Get full text
    Article


Search Tools: